BioMarin Pharmaceutical Inc. Equity-NMS: BMRN

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$56.79
Open :$56.92
Today's high :$57.56
Today's low :$56.06
52W low :$52.93
52W high :$94.85
EPS(TTM): :2.7
Shares O/S :191.78 M
Market cap :10.76 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
BioMarin Pharmaceutical Inc. $56.11 -0.46% 21.03 10.76B

Frequently Asked Questions

What is the share price of BioMarin Pharmaceutical Inc. today?

BioMarin Pharmaceutical Inc. (BMRN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (BioMarin) is a global biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia.